Strain AI vs Myocardial Strain

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Strain AI
VS
by Circle Cardiovascular Imaging Inc.

AI Verdict

Tool A (Exo's Strain AI) is designed for analyzing cardiac ultrasound images to measure Global Longitudinal Strain, ideal for point-of-care or ultrasound-centric workflows. Tool B (Circle Cardiovascular Imaging's Myocardial Strain) focuses on comprehensive myocardial strain analysis using CMR and CCT images, suitable for advanced cardiac imaging departments. While both aim to assess cardiac function through AI-powered strain analysis, their distinct imaging modality focus makes them complementary rather than direct substitutes.

Choose Strain AI if…

Choose Strain AI if your primary need is real-time, on-device analysis of cardiac ultrasound images for immediate assessment of Global Longitudinal Strain (GLS). This tool is ideal for point-of-care diagnostics, especially in settings where internet connectivity is unreliable, allowing for rapid evaluation of heart function directly during an ultrasound examination.

View Strain AI →

Choose Myocardial Strain if…

Choose Myocardial Strain if your workflow requires comprehensive, in-depth analysis of cardiac function using Cardiovascular Magnetic Resonance (CMR) or Cardiac Computed Tomography (CCT) images. This solution is best suited for integrating advanced AI-powered strain quantification into an existing hospital PACS environment, enabling detailed global and regional myocardial assessment for complex diagnostic evaluations and research applications.

View Myocardial Strain →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Strain AI Myocardial Strain
Pricing Unknown Contact for pricing
Deployment API, Integrations with POS and menu sync platforms (Dutchie, Leafly, Weedmaps, Jane POS, Treez) On-premise
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Strain AI

Tool A emphasizes 'on-device AI' and 'real-time' insights, suggesting a more immediate and potentially simpler workflow integrated directly with existing ultrasound devices. This approach likely offers a more streamlined, point-of-care usability compared to Tool B's server-client architecture, which, while offering automated features, still implies a more traditional workstation-based interaction.

Clinical Value

Tie

Both tools are FDA-cleared and provide valuable AI-powered strain analysis for cardiac function. Tool A focuses on Global Longitudinal Strain (GLS) from ultrasound, a widely accessible modality for common conditions. Tool B offers broader strain quantification (longitudinal, circumferential, radial) across advanced modalities like CMR and CCT, though CCT strain is for research use only. The choice between them depends on the specific clinical context and imaging modality available, making it a tie in overall clinical value.

Pricing & Value

Tie

Neither Tool A nor Tool B publicly discloses their pricing information, requiring direct contact with the vendor for details. Without transparent pricing or specific value-add comparisons beyond their core functionalities, it is impossible to determine which tool offers superior pricing or overall value.

Enterprise Readiness

Strain AI

Tool A explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. While Tool B mentions 'likely' HIPAA compliance and BAA, it requires contacting the vendor for confirmation. Tool A's clear compliance statements provide a more definitive advantage for enterprise readiness.

Innovation

Strain AI

Tool A's focus on 'on-device AI' and integration with 'handheld ultrasound' represents a significant innovation in bringing advanced diagnostics to the point of care, potentially democratizing access and enabling real-time insights. While Tool B offers advanced AI analysis for complex modalities, Tool A's deployment model pushes the boundaries of accessibility and immediate utility in a novel way.

Support & Docs

Tie

Both Exo (for Tool A) and Circle Cardiovascular Imaging (for Tool B) appear to offer standard customer support, documentation, and educational resources through their respective websites. Without more specific details on the quality, responsiveness, or breadth of these offerings for either product, it is difficult to distinguish between them.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Strain AI Myocardial Strain
Name Strain AI Myocardial Strain
Company Exo Circle Cardiovascular Imaging
Description Exo's FDA-cleared Strain AI is an AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients. Circle Cardiovascular Imaging's cvi42 platform offers AI-powered myocardial strain analysis for comprehensive assessment of cardiac function from CMR and CCT images, aiding in early detection of myocardial dysfunction.
Imaging Modalities Supported Cardiac ultrasound images Cardiovascular Magnetic Resonance (CMR) imaging, Cardiac Computed Tomography (CCT) imaging (CT Strain for research use only)
Key Measurement Global Longitudinal Strain (GLS) Longitudinal, circumferential, and radial strain

Videos

Demos, reviews, and walkthroughs featuring Strain AI and Myocardial Strain.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Exo's Strain AI analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS). Circle Cardiovascular Imaging's Myocardial Strain platform supports analysis from Cardiovascular Magnetic Resonance (CMR) and Cardiac Computed Tomography (CCT) images, though CCT strain is for research use only.
Exo's Strain AI specifically measures Global Longitudinal Strain (GLS) to assess heart function. Circle Cardiovascular Imaging's Myocardial Strain provides quantification of longitudinal, circumferential, and radial strain for comprehensive cardiac function assessment.
Strain AI aids physicians in assessing heart function and detecting conditions such as heart failure (CHF, HFpEF, HFrEF), cardiotoxicity, and hypertrophy in adult patients. Myocardial Strain aids in the early detection of myocardial dysfunction.
Exo's Strain AI supports diagnostic evaluation without manual image interpretation, delivering real-time, on-device AI insights. Circle Cardiovascular Imaging's Myocardial Strain features semi-automated endocardial and epicardial contour delineation and automated tracking of myocardial features.
Strain AI focuses on providing quantitative GLS measurements to aid in assessing heart function. Myocardial Strain offers assessment of both global and regional myocardial function through its various strain quantifications.
AI Tool Finder
AI-powered search. Results may not be comprehensive.